Sensei Biotherapeutics, Inc.
SNSE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $551 | $571 | $1,808 | $685 |
| Gross Profit | -$551 | -$571 | -$1,808 | -$685 |
| % Margin | – | – | – | – |
| R&D Expenses | $18,627 | $18,299 | $29,583 | $21,662 |
| G&A Expenses | $0 | $18,665 | $0 | $0 |
| SG&A Expenses | $12,485 | $18,765 | $17,729 | $15,135 |
| Sales & Mktg Exp. | $0 | $100 | $0 | $0 |
| Other Operating Expenses | $0 | -$571 | $0 | $0 |
| Operating Expenses | $31,112 | $36,493 | $47,312 | $36,797 |
| Operating Income | -$31,663 | -$37,064 | -$49,120 | -$37,482 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,506 | $2,963 | $532 | $688 |
| Pre-Tax Income | -$30,157 | -$34,101 | -$48,588 | -$36,794 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$30,157 | -$34,101 | -$48,588 | -$36,794 |
| % Margin | – | – | – | – |
| EPS | -1.2 | -1.22 | -1.58 | -1.33 |
| % Growth | 1.6% | 22.8% | -18.8% | – |
| EPS Diluted | -1.2 | -1.22 | -1.58 | -1.33 |
| Weighted Avg Shares Out | 25,117 | 27,952 | 30,703 | 27,711 |
| Weighted Avg Shares Out Dil | 25,117 | 27,953 | 30,703 | 27,711 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,550 | $3,624 | $1,783 | $800 |
| Interest Expense | $90 | $144 | $219 | $670 |
| Depreciation & Amortization | $551 | $3,678 | $1,808 | $685 |
| EBITDA | -$29,516 | -$33,386 | -$46,561 | -$35,439 |
| % Margin | – | – | – | – |